Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FD5PY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,316
Award facts
- Contract value 100% obligated
- $83,316.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $83,316.00 by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order is scheduled for completion by September 25, 2025, with performance to take place at the contractor's Park Ridge facility. The award carries no set-aside designation, indicating the company competed on an unrestricted basis in the federal procurement market.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. Nexplanon implants, a long-acting reversible contraceptive device, represent part of the company's extensive pharmaceutical portfolio that includes prescription medications, biologics, and medical consumables. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated capability in delivering specialized pharmaceutical products directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FD5PY?
SPE2DB25FD5PY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FD5PY worth?
The government has obligated $83,316 on SPE2DB25FD5PY.
Is contract SPE2DB25FD5PY an order under another contract?
Yes. SPE2DB25FD5PY is a delivery order under SPE2DB20D9759, an indefinite delivery contract.
Was contract SPE2DB25FD5PY competed?
The extent of competition for SPE2DB25FD5PY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award